Gene Therapy, A Novel Therapeutic Tool for Neurological Disorders: Current Progress, Challenges and Future Prospective

Abstract

: Neurological disorders are one of the major threat for health care system as it puts enormous socioeconomic burden. All aged population are susceptible to one or other neurological problems with symptoms of neuroinflammation, neurodegeneration and cognitive dysfunction. At present available pharmacotherapeutics are insufficient to treat these diseased conditions and in most cases they provide only palliative effect. It was also found that the molecular etiology of neurological disorders are directly linked with the alteration in genetic makeup which can be inherited or triggered by the injury, environmental toxins and by some existing disease. Therefore, to take care of this situation, gene therapy has emerged as an advanced modality that claims to permanently cure the disease by deletion, silencing or edition of faulty genes and by insertion of healthier genes. In this modality, vectors (viral and non-viral) are used to deliver targeted gene into a specific region of the brain via various routes. At present, gene therapy has shown positive outcomes in complex neurological disorders, such as Parkinson's disease, Alzheimer's disease, Huntington disease, Multiple sclerosis, Amyotrophic lateral sclerosis and in lysosomal storage disease. However, there are some limitations such as immunogenic reactions non-specificity of viral vectors and lack of effective biomarkers to understand the efficacy of therapy. Considerable progress has been made to improve vector design, gene selection and targeted delivery. This review article deals with the current status of gene therapy in neurological disorders along with its clinical relevance, challenges and future prospective.

ReRF-Pred: predicting amyloidogenic regions of proteins based on their pseudo amino acid composition and tripeptide composition

“…Ensemble learning is a hot topic in machine learning-related fields in recent years [ 58 – 60 ]. Its idea is to obtain better performance by combining the classification results of multiple single classifiers.…”

The role and mechanisms of Microglia in Neuromyelitis Optica Spectrum Disorders

“…The effect and application of haematopoietic stem cell transplantation on microglia should be further investigated in patients with NMOSD. Although there are some limitations, such as immunogenic reactions and a lack of specificity of viral vectors, gene therapy has been applied with positive outcomes in neurological diseases, including MS 82 . Insulin-like growth factor 1 (IGF1) gene therapy could target microglia, modify the inflammatory response and improve cognitive or motor deficits 83 .…”

The role of CRISPR‐Cas in advancing precision periodontics

“…The development of the CRISPR–Cas9 system has led to speculation by clinicians about its potential as a therapeutic agent to treat patients suffering from numerous diseases, including malignancies, 27 genetic conditions, 28 and neurological disorders 29 . Genetic editing has consistently drawn the attention of the scientific community as a potential therapeutic strategy, 30 and CRISPR–Cas9 has proven to be no exception.…”